Michael Wang, MD, discusses the approaches physicians can use when treating their patients with mantle cell lymphoma who have become resistant to cellular therapies, such as CAR T-cell therapy.
Videos
Ruben Mesa, MD, discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms.
Joseph Chao, MD, discusses the importance of assessing the microsatellite instability (MSI) status in patients with advanced gastric/gastroesophageal junction cancer based on findings from a comparative analysis of KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Targeting HER2-Low Breast Cancer: the ARX788 Phase 2 Clinical Trial
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
FDA Fast-Tracks Muzastotug Combo in MSS Metastatic Colorectal Cancer
4
Early Relapse Guides Use of CAR T vs Other Options in LBCL
5